According to AlphaMoat, in October 2026 InpharmD (inpharmd.com) received 22,590 monthly visits (+59.1% MoM) — ranked #7,153 of 17,609 AI websites with traffic data, and #945 of 3,112 in Industry Services; its largest market is United States (82.3% of visits).
InpharmD provides drug-information and literature-search services for clinical pharmacists: users raise clinical questions anytime, anywhere, and the platform completes customized literature searches and returns evidence-based answers usable for decisions—like adding a virtual drug-information pharmacist to a hospital without adding headcount.
| Month | Monthly visits | MoM |
|---|---|---|
| 2026-06 | 12.9K | — |
| 2026-07 | 15.6K | +21.0% |
| 2026-08 | 16.0K | +2.6% |
| 2026-09 | 14.2K | -11.1% |
| 2026-10 | 22.6K | +59.1% |
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ CompareA platform connecting specialists with model research, training, and evaluation projects
+ CompareA conversational hiring agent that moves candidates from application through onboarding
+ CompareA talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ CompareA clinician platform combining communication, telehealth, and AI-assisted documentation
+ CompareAn AI research and search platform built for professional investors
+ CompareAccording to AlphaMoat, InpharmD (inpharmd.com) received 22,590 visits (about 22.6K) in October 2026 (+59.1% month over month), ranking #7,153 of 17,609 AI websites with traffic data, and #945 in Industry Services.
In October 2026, InpharmD’s largest markets by share of visits are United States 82.3%, India 15.0%, Pakistan 2.5%.
In Industry Services, the other products with the most monthly visits are Ashby (28.4M), Mercor (14.2M), Paradox (11.4M), Eightfold AI (11.0M), Doximity (10.0M).
Data month: 2026-10 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.